Clinical Trial Update: ARN-75039 Lassa Fever Treatment in West Africa [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ARN-75039 for Lassa fever in West Africa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lassa Fever

Drugs mentioned

• ARN-75039

Snippet

Sponsor: Arisan Therapeutics, Inc. | Conditions: Lassa Fever | Phase 2 | Status: RECRUITING